Which of the following is not included in the types of studies eligible under Standard 1.9?

Standard 1.9 of the Commission on Cancer (CoC) outlines the types of studies that hospitals and cancer programs should engage in to promote quality improvement and patient care. Typically, the focus of eligible studies includes those that enhance understanding of treatment outcomes, patient experiences, and the efficacy of various medical interventions.

Cognitive studies, which might focus on aspects such as mental processes, cognition, or the psychological impact of cancer and its treatment, do not fit into the categories of research deemed eligible under Standard 1.9. This standard emphasizes research with direct relevance to clinical practices, outcome improvements, and quality of life in relation to cancer treatment, where cognitive studies may not provide that direct benefit or relevance to the field.

In contrast, genetic studies, quality-of-life trials, and diagnostic trials are directly related to cancer research and focus on improving patient outcomes and clinical practices. Genetic studies may explore the genetic basis of cancer and how it might influence treatment options, quality-of-life trials assess how cancer and its treatment affect patients' daily living, and diagnostic trials evaluate new methods for detecting cancer. These align closely with the goals set forth in the CoC standards, focusing on enhancing patient care through rigorous scientific inquiry. Thus, cognitive studies stand apart as they do